Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 541625 of 542236 entries
View as:

Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients

Phase: N/A Priority: Normal
NCT ID: NCT06053619 Org: User:
Start: 11/20/23 End: 09/11/25 Due: 09/11/26

Anti Reflux Mucosal Ablation Therapy in PPI Dependent GERD

Phase: N/A Priority: Normal
NCT ID: NCT05763485 Org: User:
Start: 03/01/23 End: 03/01/25 Due: 03/01/26

Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT02294435 Org: User:
Start: 02/28/15 End: 12/31/29 Due: 12/31/30

Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin

Phase: N/A Priority: Normal
NCT ID: NCT02624414 Org: User:
Start: 02/06/15 End: 05/05/22 Due: 05/05/23

Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT06780241 Org: User:
Start: 12/10/24 End: 12/31/30 Due: 12/31/31

An Adaptive Prenatal Intervention to Increase Childhood Vaccinations

Phase: N/A Priority: Normal
NCT ID: NCT05795855 Org: User:
Start: 04/27/24 End: 12/31/25 Due: 12/31/26

Chlorzoxazone in Hip and Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT02405104 Org: User:
Start: 09/01/15 End: 07/31/19 Due: 07/31/20

#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04385264 Org: User:
Start: 01/31/22 End: 12/31/22 Due: 12/31/23

Group-based Integrative Pain Management (IPMP+ Pilot)

Phase: N/A Priority: Normal
NCT ID: NCT05906784 Org: User:
Start: 04/28/23 End: 12/04/23 Due: 12/04/24

Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT04988490 Org: User:
Start: 10/11/21 End: 06/14/24 Due: 06/14/25

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance

Phase: N/A Priority: Normal
NCT ID: NCT01187719 Org: User:
Start: 05/31/10 End: 09/30/12 Due: 09/30/13

Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP

Phase: N/A Priority: Normal
NCT ID: NCT03562832 Org: User:
Start: 06/20/18 End: 08/01/24 Due: 08/01/25

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)

Phase: N/A Priority: Normal
NCT ID: NCT04768998 Org: User:
Start: 11/04/20 End: 09/30/23 Due: 09/30/24

Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)

Phase: N/A Priority: Normal
NCT ID: NCT06103669 Org: User:
Start: 10/05/23 End: 01/05/31 Due: 01/05/32

A Study of LY3841136 in Overweight and Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06345066 Org: User:
Start: 04/03/24 End: 10/31/25 Due: 10/31/26

Comparison of the Analgesic Effect of 2 Shoulder Infiltrations

Phase: N/A Priority: Normal
NCT ID: NCT05408065 Org: User:
Start: 11/15/22 End: 12/31/26 Due: 12/31/27

Dynamic Gait Index in Children With Dyslexia

Phase: N/A Priority: Normal
NCT ID: NCT04235465 Org: User:
Start: 04/02/18 End: 07/31/18 Due: 07/31/19

Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study

Phase: N/A Priority: Normal
NCT ID: NCT02776267 Org: User:
Start: 05/31/15 End: 06/30/18 Due: 06/30/19

Efficacy Study of Acupuncture on Spinal Compression Fracture

Phase: N/A Priority: Normal
NCT ID: NCT01913587 Org: User:
Start: 03/31/13 End: 03/31/14 Due: 03/31/15

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00617539 Org: User:
Start: 02/28/05 End: 01/31/14 Due: 01/31/15

A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05187624 Org: User:
Start: 04/05/22 End: 05/14/25 Due: 05/14/26

Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02763228 Org: User:
Start: 03/16/16 End: 11/06/20 Due: 11/06/21

Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT05327621 Org: User:
Start: 05/01/22 End: 03/20/25 Due: 03/20/26

Semaglutide in Treatment of Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06604624 Org: User:
Start: 09/20/24 End: 03/01/26 Due: 03/01/27

Sugammadex Dose Finding Under Two Years Old

Phase: N/A Priority: Normal
NCT ID: NCT06575036 Org: User:
Start: 09/15/24 End: 05/31/25 Due: 05/31/26